ArticleJournal of pharmacy & bioallied sciences2024
Longitudinal Analysis of Risk Factors and Outcomes in Patients with Atrial Fibrillation: Stroke and Bleeding Events.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: " Objective: This longitudinal research aimed to assess the risk factors and outcomes in subjects with AF over a specified period, focusing on stroke and bleeding events. Methods: Electronic health records of AF subjects were analyzed over a defined research period. Demographic information, comorbidities, medication history, and laboratory parameters were extracted. Stroke and bleeding events were identified, and statistical analyses were performed. Results: The research cohort comprised 800 AF subjects with a mean follow-up duration of 3 years. Significant risk factors for stroke and bleeding events included advancing age, hypertension, and anticoagulant use. The incidence of stroke and bleeding events augmented over the follow-up period, with notable differences in rates between patient subgroups. Conclusion: This longitudinal analysis provides valuable insights into the risk factors and outcomes connected with AF, particularly stroke and bleeding events. The findings underscore the importance of proactive management strategies and personalized care approaches to optimize patient outcomes in AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.